Procore Technologies (NYSE:PCOR) Director Sells $94,500.00 in Stock
Procore Technologies director Elisa Steele sold 1,500 shares of PCOR stock for $94,500, reducing her holdings by 2.51%. The sale was part of a pre-arranged trading plan. Procore recently reported strong quarterly earnings, surpassing analyst expectations, and maintains a "Moderate Buy" consensus rating from analysts with a price target of $70.44.
Arch Capital Group (NASDAQ:ACGL) CFO Francois Morin Sells 11,010 Shares of Stock
Arch Capital Group's CFO, Francois Morin, sold 11,010 shares of company stock for approximately $1.09 million, reducing his stake by 5.62%. The company's shares are trading at $99.31, with a market capitalization of $33.89 billion. Arch Capital Group recently surpassed quarterly earnings expectations, and analysts maintain a "Hold" rating with an average price target of $111.11.
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 34,980 Shares of Stock
BridgeBio Pharma CEO Neil Kumar sold 34,980 shares of the company's stock for approximately $2.89 million, reducing his holdings by 12.57%. This sale occurred as BridgeBio reported a quarterly loss that missed analyst estimates, although revenue saw a significant year-over-year increase. Despite the insider selling and a slight stock decline, analysts maintain a "Moderate Buy" rating with an average price target of $100.79.
Corcept Therapeutics (NASDAQ:CORT) Director Sells 103,606 Shares
Corcept Therapeutics Director David Mahoney sold 103,606 shares for approximately $12.25 million, reducing his stake by 8.37%. The company's shares are trading near a 52-week high, with a market capitalization of $13.09 billion and a high P/E ratio. Recent earnings exceeded expectations, and analysts maintain a "Moderate Buy" consensus with an average price target of $138.17.
Curbline Properties (NYSE:CURB) Director Sells $988,468.54 in Stock
Curbline Properties (NYSE:CURB) Director Alexander Otto sold 32,927 shares of the company's stock for approximately $988,469 on August 18th, reducing his position by 0.45%. This sale is part of multiple transactions by Otto in August, totaling millions of dollars. Despite the insider selling, analysts maintain a "Moderate Buy" consensus for CURB with an average price target of $31.11, following the company's strong quarterly earnings beat.
Credo Technology Group (NASDAQ:CRDO) Trading Down 1.5% - What's Next?
Credo Technology Group (NASDAQ:CRDO) shares fell 1.5% on Thursday, trading at $231.35 with lower-than-average volume. Despite recent downgrades to "Hold" by some firms, analysts maintain a "Moderate Buy" consensus rating with an average price target of $268.39. The company reported strong quarterly results, including $1.16 EPS and $437 million in revenue, a 157% increase year-over-year.
Insider Selling: American Integrity Insurance Group (NYSE:AII) CEO Sells 12,000 Shares of Stock
American Integrity Insurance Group (NYSE:AII) CEO Robert Ritchie recently sold 12,000 shares of the company's stock for over $304,000, reducing his direct stake by 0.56%. This sale comes as the company's shares rose 1.9%, and it reported quarterly earnings significantly above analyst estimates. The company maintains a "Moderate Buy" consensus rating from analysts, with institutional investors showing increased interest in the second quarter.
Lorena Raquel Lerner Sells 3,568 Shares of Keros Therapeutics (NASDAQ:KROS) Stock
Lorena Raquel Lerner, an insider at Keros Therapeutics (NASDAQ:KROS), sold 3,568 shares for $36,714.72 to cover tax withholding obligations related to vested equity awards, reducing her ownership by 11.46%. The company is facing weak financial performance with a recent quarterly loss and its stock trading near a 12-month low. Analyst ratings are mixed, with a consensus "Hold" and an average target price of $20.50.
Gerhard Lombard Acquires 2,000 Shares of Crescent Capital BDC (NASDAQ:CCAP) Stock
CFO Gerhard Lombard purchased 2,000 shares of Crescent Capital BDC (NASDAQ:CCAP) stock on August 19th for $10.91 per share, increasing his direct ownership by 5.19%. This transaction brings his total holdings to 40,509 shares, valued at $441,953.19. The company's shares are trading near their 52-week low after missing quarterly EPS estimates, and analysts currently have a "Hold" rating with a target price of $13.10.
Insider Selling: Ziff Davis (NASDAQ:ZD) Director Sells 2,513 Shares of Stock
Ziff Davis (NASDAQ:ZD) Director W. Brian Kretzmer recently sold 2,513 shares of the company's stock for a total of $138,994.03, reducing his stake by 11.16% to 20,000 shares. The sale occurred while ZD shares were trading near their 52-week high, and the company had reported strong quarterly EPS that beat analyst estimates, despite a revenue decline. Analyst sentiment for Ziff Davis is mixed, with an average price target of $56.62.
GlobalM Brings GMX Broadcast Platform to Oracle Cloud Infrastructure
GlobalM is integrating its GMX software-defined media platform with Oracle Cloud Infrastructure (OCI) to expand global access for live media workflows. This collaboration will allow GMX Cloud services to run across OCI regions, offering broadcasters and media companies dynamic deployment and scaling of resources for live productions. The partnership leverages OCI's high-performance networking and flexible compute architecture, alongside GlobalM's distributed architecture, to optimize media contribution, processing, and distribution.
Immatics (NASDAQ:IMTX) Shares Down 8% - Should You Sell?
Immatics (NASDAQ:IMTX) shares fell 8% to $8.51, trading below its 50-day and 200-day moving averages after missing quarterly earnings and revenue expectations. Despite recent downgrades from some firms, the company maintains a "Moderate Buy" consensus rating from analysts with an average price target of $20.80. Hedge funds and institutional investors collectively own 64.41% of the clinical-stage biotechnology company.
Innio (NASDAQ:INIO) Trading Down 7.4% - Should You Sell?
Innio (NASDAQ:INIO) shares dropped 7.4% to $23.37 during mid-day trading with significantly lower than average volume. Despite this decline, analysts maintain a "Moderate Buy" consensus rating and an average price target of $42.90. The company recently surpassed quarterly earnings estimates, reporting $0.08 EPS against a $0.05 estimate, and analysts anticipate $0.37 EPS for the current fiscal year.
Snowflake Rides on AI Momentum: Can It Stay Ahead of DELL and Oracle?
Snowflake is leveraging AI momentum with products like Snowflake Intelligence and Cortex Code, leading to a 34% rise in product revenues in Q1 fiscal 2027. The company's cloud-native architecture and AI integration differentiate it from competitors like Dell and Oracle, who are also expanding their AI footprints. Snowflake expects continued growth, with a 31% product revenue increase projected for fiscal 2027, despite trading at a premium valuation.
Prime Medicine (NASDAQ:PRME) Trading Down 6.9% - Should You Sell?
Prime Medicine (NASDAQ:PRME) saw its shares drop by 6.9% to approximately $3.30, with a significantly reduced trading volume compared to its average. Despite a consensus "Moderate Buy" rating and an average price target of $7.69 from analysts, the company reported a quarterly loss of $0.24 per share and revenue below estimates. Institutional investors have recently modified their holdings, with some acquiring new stakes and others increasing their positions.
AMA, DiMe launch AI framework for physicians amid rapid tech progress
The American Medical Association (AMA) and the Digital Medicine Society (DiMe) have released a new framework and roadmap for physicians navigating the rapidly evolving landscape of AI in healthcare. This initiative aims to define physicians' enduring responsibilities, emphasizing patient trust, clinical judgment, and safe implementation of technology, amid discussions about AI's potential to transform or even surpass human medical expertise. The framework outlines five key responsibilities for physicians and suggests collaborative actions for various stakeholders, including patients, developers, and policymakers.
Bitdeer Technologies Group (NASDAQ:BTDR) Sees Strong Trading Volume - Time to Buy?
Bitdeer Technologies Group (NASDAQ:BTDR) experienced strong trading volume despite a 26% decline from the previous session. The company's shares jumped to $10.44, up from a prior close of $9.63, while analyst sentiment remains a "Moderate Buy" with an average target price of $24. Despite reporting a quarterly loss, two insiders recently purchased a combined 50,000 shares, and institutional investors own 22.25% of the stock.
QXO (NYSE:QXO) Stock Price Down 6% - Here's Why
QXO (NYSE:QXO) stock experienced a 6% decline during mid-day trading on Thursday, with trading volume significantly below average. Despite the drop, analysts maintain a "Moderate Buy" consensus rating and a target price of $29.71. The company met EPS expectations and exceeded revenue forecasts, but continues to report a negative net margin.
Park Aerospace (NYSE:PKE) Shares Gap Down - Here's What Happened
Park Aerospace (NYSE:PKE) shares gapped down by 1.5% at market open, trading at $35.36 after closing at $36.90. Despite this, analysts maintain a "Buy" rating with an average price target of $42.50. The company exceeded quarterly expectations with EPS of $0.17 and revenue of $18.31 million, also announcing a quarterly dividend of $0.125 per share.
Can EPAM Systems (NYSE:EPAM) Rebound After Guidance Reset?
EPAM Systems has re-entered market focus after its latest quarterly update, revised guidance, and progress on its share repurchase program. The company's recent momentum, contrasted with prior weakness, has led to renewed discussions about its valuation, particularly as it navigates evolving digital engineering conditions and increasing enterprise technology spending, especially in AI. The article explores how new project demand, client budgets, and the ability to integrate AI capabilities will be crucial for EPAM's sustained recovery and future performance.
Royal Bank Of Canada Boosts Jack Henry & Associates (NASDAQ:JKHY) Price Target to $178.00
Royal Bank of Canada has raised its price target for Jack Henry & Associates (NASDAQ:JKHY) to $178.00 from $173.00, maintaining an "outperform" rating due to the company exceeding quarterly earnings expectations. Jack Henry reported EPS of $1.57 and revenue of $633.1 million, surpassing analyst estimates, with strong performance in processing, cloud hosting, and faster-payment growth. Despite positive guidance for FY 2027, the company faces profitability concerns with a decline in GAAP EPS and operating income year-over-year.
Sidoti Issues Optimistic Forecast for FLXS Earnings
Sidoti has issued an optimistic forecast for Flexsteel Industries (FLXS) earnings, raising EPS estimates for Q2 FY2027 to $1.30 and FY2027 to $5.29, with FY2028 projected at $6.05. This positive outlook follows Flexsteel's recent quarterly results, which surpassed analyst expectations with an EPS of $1.33 and revenue of $115.37 million. Despite the improved forecasts and a recent dividend increase to $0.25 per share, analyst sentiment remains cautious with a consensus "Hold" rating, citing ongoing risks from inflation, tariffs, and uneven consumer demand.
Ascendiant Capital Markets Issues Pessimistic Forecast for Travelzoo (NASDAQ:TZOO) Stock Price
Ascendiant Capital Markets lowered its price target for Travelzoo (NASDAQ:TZOO) from $23.00 to $20.00 but maintained a "buy" rating, indicating a potential upside of 190.70% from its previous close. Despite this, analyst sentiment remains mixed, with a consensus "hold" rating and an average target of $13.83. Travelzoo recently reported a quarterly loss of $0.21 per share and revenue of $23.21 million, both missing analyst estimates.
26,280 Shares in Haemonetics Corporation $HAE Acquired by Nierenberg Investment Management Company LLC
Nierenberg Investment Management Company LLC has acquired 26,280 shares of Haemonetics Corporation (NYSE:HAE) valued at approximately $1.97 billion, making it their 15th largest holding. This acquisition comes amid positive investor sentiment for Haemonetics, driven by a new supply agreement with CSL Plasma, strong quarterly results with raised revenue-growth forecasts, and recent analyst upgrades. The company's stock opened at $108.39, near its 12-month high, while analysts maintain a "Moderate Buy" consensus rating with an average price target of $95.00.
Westport Asset Management Inc. Invests $4.25 Million in Check Point Software Technologies Ltd. $CHKP
Westport Asset Management Inc. has acquired a new stake of 32,300 shares, valued at $4.25 million, in Check Point Software Technologies Ltd. (NASDAQ:CHKP), making it their 20th-largest portfolio holding. Despite institutional investors owning 98.51% of the company, analyst sentiment is mixed, with a consensus "Hold" rating and an average target price of $149.67. Check Point Software Technologies recently exceeded quarterly earnings expectations with an EPS of $2.55 and revenue of $673.6 million.
Somerville Kurt F Invests $3.94 Million in ASML Holding N.V. $ASML
Somerville Kurt F has acquired a new stake of 2,010 shares in ASML Holding N.V. (NASDAQ:ASML) worth approximately $3.94 million during the second quarter. Other institutional investors have also adjusted their positions in the semiconductor company. ASML maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $1,970.33, following strong quarterly earnings and a declared dividend.
36,484 Shares in AptarGroup, Inc. $ATR Bought by Notis McConarty Edward
Notis McConarty Edward recently acquired 36,484 shares of AptarGroup, Inc. (NYSE:ATR) worth approximately $4.6 million, making it a significant holding in their portfolio. Despite this institutional buying, company insiders have sold 22,247 shares valued at $2.94 million over the past three months. AptarGroup reported strong quarterly earnings, beating estimates with $1.42 EPS and a 6.3% increase in revenue, and has a "Moderate Buy" consensus rating from analysts with an average price target of $172.80.
Western Standard LLC Takes $4.45 Million Position in Inhibrx Biosciences, Inc. $INBX
Western Standard LLC has acquired a new position in Inhibrx Biosciences, Inc. (NASDAQ:INBX), purchasing 47,000 shares valued at approximately $4.45 million, making it the fund's 19th largest holding. Despite this institutional interest, analyst sentiment is mixed, with a consensus "Hold" rating and an average price target of $150. Inhibrx Biosciences recently reported a quarterly loss of $2.34 per share, missing consensus estimates.
Nierenberg Investment Management Company LLC Makes New Investment in Expand Energy Corporation $EXE
Nierenberg Investment Management Company LLC has acquired a new stake of 15,555 shares, valued at $1.42 billion, in Expand Energy Corporation ($EXE) during the second quarter, making it their 19th largest holding. Expand Energy (NASDAQ:EXE) beat quarterly EPS estimates and announced a dividend, while institutional investors now own 97.93% of the company. Despite some analyst downgrades and price target reductions, the consensus rating remains "Moderate Buy" with an average target price of $127.67.
Madison Asset Management LLC Takes Position in MSCI Inc $MSCI
Madison Asset Management LLC has acquired a new position in MSCI Inc (NYSE:MSCI) during the second quarter, purchasing 70,420 shares valued at approximately $39.44 million. This move makes Madison Asset Management LLC a significant institutional holder, owning about 0.10% of MSCI. The article also details other institutional investor activities, analyst ratings, MSCI's stock performance, recent earnings, and dividend announcements.
Notis McConarty Edward Acquires Shares of 7,337 Emerson Electric Co. $EMR
Notis McConarty Edward recently acquired 7,337 shares of Emerson Electric Co. (NYSE:EMR) worth approximately $1.05 million. Institutional investors collectively own 74.3% of the company, which reported strong quarterly earnings, beating analyst estimates, and reaffirmed its fiscal 2026 EPS guidance. Analysts generally maintain a "Moderate Buy" rating for EMR with an average price target of $166.96, and the company declared a quarterly dividend of $0.555 per share.
Madison Asset Management LLC Makes New Investment in Labcorp Holdings Inc. $LH
Madison Asset Management LLC has made a significant new investment in Labcorp Holdings Inc. (NYSE:LH), purchasing over 476,000 shares valued at approximately $133.46 million, making it their 13th largest holding. Other institutional investors have also adjusted their positions in Labcorp, and company insiders have recently sold shares. Labcorp reported strong quarterly earnings, beating analyst expectations, and several analysts have set new price targets for the stock, with a consensus "Moderate Buy" rating.
Madison Asset Management LLC Makes New Investment in Teledyne Technologies Incorporated $TDY
Madison Asset Management LLC has acquired a new stake in Teledyne Technologies Incorporated (NYSE:TDY), purchasing 183,824 shares valued at approximately $122.59 million. This investment makes Teledyne Technologies the 18th largest holding in Madison Asset Management's portfolio, representing about 1.5% of their total assets. Other institutional investors have also recently adjusted their holdings in TDY, while a director sold 6,449 shares.
Notis McConarty Edward Takes Position in Rockwell Automation, Inc. $ROK
Notis McConarty Edward recently acquired a new position in Rockwell Automation, Inc. (NYSE:ROK) during the second quarter, purchasing 15,796 shares valued at approximately $7.82 million. This investment now constitutes 3.4% of Notis McConarty Edward's holdings, making Rockwell Automation its tenth-largest holding. Other institutional investors have also adjusted their positions in the company, which recently reported strong earnings, beat analyst estimates, and announced a share buyback program and a quarterly dividend.
Madison Asset Management LLC Invests $131.57 Million in Liberty Media Corporation - Liberty Formula One Series A $FWONA
Madison Asset Management LLC has acquired a new position in Liberty Media Corporation - Liberty Formula One Series A (NASDAQ:FWONA), purchasing shares valued at approximately $131.57 million in the second quarter. This investment makes FWONA the 14th largest holding in Madison Asset Management LLC's portfolio, representing 1.6% of their total investments. Other institutional investors have also adjusted their holdings in the company, which has seen recent analyst upgrades and insider selling.
323,573 Shares in Intercontinental Exchange Inc. $ICE Bought by Madison Asset Management LLC
Madison Asset Management LLC has acquired a new stake of 323,573 shares in Intercontinental Exchange Inc. (NYSE:ICE) during the second quarter, valued at approximately $39,835,000. Other hedge funds and institutional investors also increased their holdings in ICE, with institutional ownership reaching 89.30%. The stock currently has a "Moderate Buy" rating from analysts, with an average price target of $183.33, and the company recently outperformed earnings expectations.
Westport Asset Management Inc. Buys New Shares in Akamai Technologies, Inc. $AKAM
Westport Asset Management Inc. has acquired a new stake of 27,700 shares in Akamai Technologies, Inc. (NASDAQ:AKAM) during the second quarter, valued at approximately $3.27 million. This investment makes Akamai Technologies the 26th largest position in Westport Asset Management Inc.'s portfolio, accounting for about 1.3% of its total holdings. Despite mixed analyst ratings, with a consensus "Hold" and a price target of $144.14, Akamai recently exceeded quarterly earnings and revenue expectations.
Westport Asset Management Inc. Invests $3.53 Million in PTC Inc. $PTC
Westport Asset Management Inc. has invested $3.53 million in PTC Inc. (NASDAQ:PTC), acquiring 31,100 shares during the second quarter, making it 1.4% of their portfolio. Institutional investors collectively own 95.14% of PTC. The company recently reported Q2 EPS of $1.58, slightly exceeding expectations, but revenue decreased by 6.8% year-over-year to $600.05 million.
Lisanti Capital Growth LLC Takes $1.59 Million Position in Guardant Health, Inc. $GH
Lisanti Capital Growth LLC has acquired a new stake of 10,610 shares in Guardant Health, Inc. (NASDAQ:GH) during the second quarter, valued at approximately $1.59 million. This move is part of a broader trend of institutional investment in Guardant Health, with several other large investors also either adding to or initiating positions in the company. Despite significant insider selling activity, analysts have largely maintained "buy" or "outperform" ratings, with an average price target of $183.78 for the stock.
Live Oak Investment Partners Acquires New Position in Howmet Aerospace Inc. $HWM
Live Oak Investment Partners has acquired a new position in Howmet Aerospace Inc., purchasing 5,809 shares valued at approximately $1.56 million. Other institutional investors also adjusted their holdings, contributing to hedge funds owning 90.46% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for HWM, with several firms raising their price targets after the company exceeded quarterly earnings expectations and increased its quarterly dividend.
Madison Asset Management LLC Buys New Position in Armata Pharmaceuticals, Inc. $ARMP
Madison Asset Management LLC has acquired a new position in Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP), purchasing over 2.1 million shares valued at approximately $13.65 million, giving it a 5.74% stake in the company. Other institutional investors like BlackRock Inc. also initiated or increased their holdings, though overall institutional ownership remains low at 3.57%. Despite the stock opening at $5.07, well below its 52-week high, analysts maintain a "Moderate Buy" consensus with an average price target of $15, supported by the company's focus on developing bacteriophage therapies for antibiotic-resistant infections.
Lisanti Capital Growth LLC Invests $2 Million in Universal Technical Institute Inc $UTI
Lisanti Capital Growth LLC has acquired 46,715 shares of Universal Technical Institute (NYSE:UTI), valued at approximately $2 million, marking a new stake in the company. Institutional investors collectively own 75.67% of UTI, which recently reported Q2 EPS of $0.04, exceeding estimates, though revenue slightly missed expectations. Despite significant insider selling totaling over $128 million in the past quarter, analysts maintain a "Moderate Buy" rating with a consensus target price significantly above the current stock price.
HC Wainwright Forecasts Aemetis' Q3 Earnings (NASDAQ:AMTX)
HC Wainwright has revised its Q3 2026 EPS forecast for Aemetis (NASDAQ:AMTX) to a narrower loss of $0.19 per share, an improvement from their prior estimate of $0.33. The firm anticipates Aemetis will reach profitability by 2028. Despite missing revenue forecasts, Aemetis reported a Q2 loss of $0.13 per share, outperforming consensus estimates.
Lisanti Capital Growth LLC Buys Shares of 21,410 MaxLinear, Inc $MXL
Lisanti Capital Growth LLC has acquired a new stake of 21,410 shares in MaxLinear, Inc (NASDAQ:MXL) during the second quarter, valued at approximately $2.74 million. This move comes amidst mixed analyst sentiment, strong quarterly financial results for MaxLinear, but also significant insider selling by the CEO and GAAP unprofitability. The company's stock has seen considerable volatility and mixed signals from both institutional interest and insider actions.
Madison Asset Management LLC Purchases Shares of 342,975 Marsh & McLennan Companies, Inc. $MRSH
Madison Asset Management LLC has acquired 342,975 shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH), valued at approximately $57.2 million. This acquisition is part of broader institutional ownership, with 87.99% of the company's stock held by institutional investors. Marsh & McLennan also reported strong quarterly earnings, surpassing analyst expectations, and increased its quarterly dividend.
Lisanti Capital Growth LLC Makes New $2.91 Million Investment in Power Integrations, Inc. $POWI
Lisanti Capital Growth LLC has made a new $2.91 million investment in Power Integrations, Inc. (NASDAQ:POWI), acquiring 34,790 shares of the semiconductor company. This investment comes as several other institutional investors have also adjusted their holdings in POWI. The company recently reported strong quarterly earnings, beating analyst estimates, although analyst sentiment remains mixed with a consensus "Hold" rating.
one8zero8 LLC Makes New $1.04 Million Investment in Miami International Holdings, Inc. $MIAX
one8zero8 LLC has acquired a new stake in Miami International Holdings, Inc. (NYSE:MIAX) worth approximately $1.04 million during the second quarter. The company reported strong quarterly earnings, beating analyst estimates with $0.48 EPS and a 34.8% increase in revenue year-over-year. Despite insider selling, analysts maintain an average "Hold" rating for MIAX with a target price of $52.00.
one8zero8 LLC Acquires Shares of 186,020 Calumet, Inc. $CLMT
one8zero8 LLC recently acquired 186,020 shares of Calumet, Inc. (NASDAQ:CLMT) worth approximately $6.7 million, making it their 17th-largest holding. This acquisition comes as Calumet reported Q2 revenue of $1.45 billion, a 40.8% year-over-year increase, but missed earnings expectations with a loss of $1.09 per share. Analyst sentiment for Calumet remains mixed, with a "Hold" consensus and an average price target of $42.75.
Tieton Capital Management LLC Makes New Investment in ADTRAN Holdings, Inc. $ADTN
Tieton Capital Management LLC has made a new investment in ADTRAN Holdings, Inc. (NASDAQ:ADTN), purchasing over 570,000 shares valued at approximately $7.9 million. This makes ADTRAN the 22nd largest position in Tieton Capital's portfolio, representing 2.3% of its holdings. Despite mixed analyst sentiment and the company missing recent earnings expectations, institutional ownership remains high at 80.56%, with several other major firms also increasing their stakes in ADTRAN.
Madison Asset Management LLC Makes New Investment in Carlisle Companies Incorporated $CSL
Madison Asset Management LLC has made a new investment in Carlisle Companies Incorporated (NYSE:CSL), purchasing 421,406 shares valued at approximately $152.9 million. This stake represents about 1.8% of Madison's portfolio and 1.06% of Carlisle's outstanding shares. Carlisle recently reported strong quarterly earnings of $7.03 per share, surpassing estimates, and increased its quarterly dividend to $1.25 per share.
